metastatic NSCLCdocetaxelplatinum therapyTJ-M2010-5
…l for concurrent use with PD-1/PD-L1 inhibitors or docetaxel in metastatic NSCLC progressing after platinum therapy. The current study examined …
1articles mentioning diseases
1disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: metastatic NSCLC ×
metastatic NSCLC
This disease is selected. Its supporting articles are shown below.